Improvement of risk prediction by genomic profiling: Reclassification measures versus the area under the receiver operating characteristic curve

American Journal of Epidemiology

Volumn 172, Issue 3, 2010, Pages 353-361

  Mihaescu, Raluca ^a   Van Zitteren, Moniek ^a   Van Hoek, Mandy ^a   Sijbrands, Eric J G ^c   Uitterlinden, André G ^c   Witteman, Jacqueline C M ^a   Hofman, Albert ^a,c   Hunink, M G Myriam ^a,b   Van Duijn, Cornelia M ^a,c   Janssens, A Cecile J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Netherlands Consortium on Healthy Aging   (Netherlands)

Author keywords

diabetes mellitus, type 2; genetic predisposition to disease; models, statistical; polymorphism, single nucleotide; risk assessment; risk factors

Indexed keywords

AGE STRUCTURE; BODY MASS; DATA SET; DIABETES; EMPIRICAL ANALYSIS; GENOMICS; NUMERICAL MODEL; POLYMORPHISM; RISK FACTOR; SEX RATIO;

AREA UNDER THE RECEIVER OPERATING CHARACTERISTIC CURVE; ARTICLE; BODY MASS; GENETIC RISK; GROUPS BY AGE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

DNA FINGERPRINTING; HUMANS; METAGENOMICS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 77955162111     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq122     Document Type: Article

References (25)

1. van Hoek M, Dehghan A, Witteman JC, et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes. 2008; 57(11):3122-3128.
2. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359(21):2220-2232.
3. Vaxillaire M, Veslot J, Dina C, et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes. 2008;57(1):244-254.
4. Morrison AC, Bare LA, Chambless LE, et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2007;166(1):28-35.
5. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36.
6. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115(7): 928-935.
7. Pepe MS, Feng Z, Huang Y, et al. Integrating the predictive-ness of a marker with its performance as a classifier. Am J Epidemiol. 2008;167(3):362-368.
8. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med. 2008;149(10):751-760.
9. Zethelius B, Berglund L, Sundström J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358(20):2107-2116.
10. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373(9665): 739-745.
11. Simmons RK, Sharp S, Boekholdt SM, et al. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? Arch Intern Med. 2008;168(11):1209-1216.
12. Paynter NP, Chasman DI, Buring JE, et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009; 150(2):65-72.
13. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassi-fication measures. Ann Intern Med. 2009;150(11):795-802.
14. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172; discussion 207-212.
15. Kathiresan S, Melander O, Anevski D, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358(12):1240-1249.
16. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359(21):2208-2219.
17. Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007; 22(11):819-829
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7): 1183-1197.
19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7): 539-553.
20. Janssens AC, Aulchenko YS, Elefante S, et al. Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med. 2006;8(7):395-400.
21. Analyse-it software. Leeds. United Kingdom: Analyse-it Software, Ltd; 2009. (http://www.analyse-it.com/). (Accessed February 4 2010).
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
23. Ihaka GR, Gentelman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5(3):299-314.
24. Harrell FE. Design and Hmisc R function library. Nashville, TN: Department of Biostatistics, Vanderbilt University; 2006. (http://biostat.mc. vanderbilt.edu/twiki/bin/view/Main/RS). (Accessed June 3, 2009).
25. Ware JH, Cai T. Comments on 'Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond' by M.J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27(2): 185-187.